for the modulation of T cell-mediated immune responses. 4, 5 Mouse LIGHT (TNFSF14) is a type II transmembrane protein of 239 amino acids with a C-terminal extracellular TNF homology domain (THD) that assembles as homotrimers capable to interact with HVEM 6 and LTβR. 7, 8 There are two isoforms of mouse LIGHT produced by alternative splicing: an isoform without transmembrane domain that resides in the cytosol, and an isoform with a transmembrane domain that can be proteolytically processed at amino acid 84 to generate a soluble extracellular form of LIGHT. 6, 9 In humans, there is an additional binding partner of LIGHT, a soluble protein named DcR3/TR6 protein (TNFRF6B) that lacks of transmembrane domain. 10, 11 Mouse LIGHT displays a pattern of expression mainly restricted to activated T cells, NK cells and bone marrow immature dendritic cells. 6, 12 Both LIGHT receptors, HVEM and LTβR, are expressed on hematopoietic and non-hematopoietic stromal cells, although the latter is not expressed on lymphoid cells. 13, 14 Whereas LIGHT/HVEM main functional activity is a cosignaling pathway in T cells, LIGHT/LTβR interaction seems to be more relevant in regulating stromal/APC/T cell cross-talk. 15 Preclinical studies in mouse models of disease are required to establish the proof of concept for the function of a target that permits to propel clinical trials in non-human short-term cytotoxic allogeneic responses, although did not fully recapitulate the impaired cytotoxic response observed in LIGHT-deficient T cells. 12 Based on some evidences in the field of transplantation using soluble LIGHT receptors as fusion proteins, such as HVEM.Ig and LTβR.Ig 16, 17, 18 and from the phenotype of LIGHT-deficient mice, 19, 12, 17 we postulated that a complete blockade of LIGHT interaction with its receptors would contribute to achieve a more suitable pharmacological control of the allogeneic immune response. LIGHT blockade on T cells would impede its interaction with LTβR or HVEM on DC and therefore would hinder their maturation, 19, 20, 21, 22 as well as would prevent T/T cell collaboration through LIGHT/HVEM interactions that would contribute to maintain T cell survival during T cell expansion and differentiation. 23, 24, 25, 26 To confirm this hypothesis, we characterized a set of anti-LIGHT antibodies raised in LIGHT-deficient mice and chose one of them that fully blocked the binding of soluble LTβR or HVEM to membrane LIGHT.
We demonstrated that efficient blockade of both HVEM/LIGHT and LTβR/LIGHT interactions attenuated the allogeneic immune response in a mouse model of graft versus host reaction and fully recapitulated the reduced cytotoxic phenotype of allogeneic LIGHT-deficient T cells. This study points to LIGHT as a suitable target for a better immunotherapeutic control of cytotoxic responses in transplantation. We also assessed the binding avidity of the Fc fragment of anti-mouse LIGHT antibody to the activating and inhibiting mouse FcγR by surface plasmon resonance.
The avidity constant (K D = Kd/Ka) for CD64 (FcγRI) and CD16.2 (FcγRIV) was 84 µM
Immunotherapeutic targeting of mouse LIGHT and 9.9 µM, whereas for CD16 (FcγRIII) and CD32 (FcγRIIB) was 0.41 µM and 0.23 µM respectively ( Figure 1C ).
We conclude from these results that 3D11 recognizes specifically mouse LIGHT but also fully inhibits the interaction of LIGHT with its receptors (HVEM and LTβR).
LIGHT protein expression is transiently detected upon polyclonal activation of T cells
As it occurs for some other members of the TNF superfamily ligands such as CD40L or human LIGHT, its expression is only transient on activated T cells, 13, 27 LIGHT is required for lymph node hypertrophy in response to antigen immunization 28 , for T cell differentiation towards effector T cells in the course of an allogeneic immune responses 29, 19 and for anti-tumor immunity. 18, 30 Due to the lack of well-characterized anti-LIGHT antibodies, the therapeutic potential of modulating LIGHT has remained 
LIGHT inhibition delays differentiation of alloreactive CD8 + T cells towards effector cells
Since LIGHT inhibition partially reduced proliferation indexes and precursor frequencies of donor alloreactive CD4 + and CD8 + T cells, we investigated whether T cell differentiation toward effector T cells had also been hampered. For this purpose, we monitored expression levels of costimulatory (BTLA, HVEM, ICOS) and differentiation (IL-7Rα, KLRG-1) molecules on host and donor CD4 + and CD8 + T cells The process of T cell activation, costimulation, clonal expansion and differentiation towards effector T cells offers potential checkpoints for immune intervention. T cell activation with no or inefficient costimulation leads to functional inactivation, unresponsiveness or impaired T cell differentiation. 38 In a previous report with a partial antagonist of the LIGHT/LTβR interaction, short-term cytotoxic response was attenuated although to a lesser extent than seen in LIGHT deficient mice. did not to achieve the same protective effect as that observed in LIGHT deficient T cells due to its partial inhibition of the LIGHT/LTβR interaction.
12
LIGHT has been proposed by several authors as a target for immunotherapy. 49, 50, 5, 26, 4, 51 Nevertheless the development of a specific anti-LIGHT reagent has been complicated until recently due to the difficulty to generate active recombinant mouse LIGHT with productive binding affinity for its receptor and functional biological activity. 52 The description, functional evaluation and validation of this anti-LIGHT antibody opens up many possibilities to study the role of LIGHT and define its by staining with propidium iodide. Samples were acquired on a Cyan 9 cytometer (Beckman Coulter, Miami, FL, USA) and data analysis was performed using WinList version 7.0 (Verity Software House, Topsham, ME, USA).
In vitro polyclonal T cell activation to induce LIGHT expression
Naïve C57BL/6 splenocytes were polyclonally activated in vitro with Phorbol Myristate Acetate (PMA, 100 ng/ml) plus ionomycin (500 ng/ml) or were left untreated for 5 h at 
Statistical analysis
Collected data from experimental and control groups were analyzed using Graph Pad 
